AtriCure is an American company that develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers. It was incorporated in 2000 and is headquartered in Mason, Ohio.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
AtriCure news
04.05.2022
AtriCure's GAAP loss for the 3 months of 2022 was $15.183 million, down 10.3% from $16.917 million in the previous year. Revenue increased 25.8% to $74.576 million from $59.275 million a year earlier.
Source: 
ir.atricure.com
ir.atricure.com
16.02.2022
AtriCure's GAAP net income for 2021 was $50.199 million, compared to a loss of $48.155 million in the previous year. Revenue increased 32.8% to $274.329 million from $206.531 million a year earlier.
Source: ir.atricure.com
ir.atricure.com
04.11.2021
AtriCure reported a GAAP net profit of $63.94 million for 9M 2021, compared to a loss of $29.593 million in the previous year. Revenues increased 35.1% to $201.111 million from $148.806 million a year earlier.
Source: ir.atricure.com
ir.atricure.com
04.08.2021
AtriCure's GAAP loss for the six months of 2021 was $33.168 million, up 34.6% from $24.644 million in the previous year. Revenue increased 38.9% to $130.651 million from $94.049 million a year earlier.
Source: ir.atricure.com
ir.atricure.com
General information
| Company name | AtriCure |
|---|---|
| Tags | #medtech |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 7555 Innovation Way Mason, OH 45040 United States |
| Mailing address | 7555 Innovation Way Mason, OH 45040 United States |
| Website | ir.atricure.com |
| Information disclosure | www.sec.gov |
English (US) 